Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ludwig Rasche & Friedemann Paul. (2018) Ozanimod for the treatment of relapsing remitting multiple sclerosis. Expert Opinion on Pharmacotherapy 19:18, pages 2073-2086.
Read now
Read now
Uwe Klaus Zettl, Michael Hecker, Orhan Aktas, Torsten Wagner & Paulus S. Rommer. (2018) Interferon β-1a and β-1b for patients with multiple sclerosis: updates to current knowledge. Expert Review of Clinical Immunology 14:2, pages 137-153.
Read now
Read now
John F Foley, Kavita V Nair, Timothy Vollmer, Judith J Stephenson, Timothy Niecko, Sonalee S Agarwal & Crystal Watson. (2017) Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis. Patient Preference and Adherence 11, pages 1035-1048.
Read now
Read now
Michael Osherov & Ron Milo. (2017) Daclizumab for the treatment of adults with relapsing forms of multiple sclerosis. Expert Review of Clinical Pharmacology 10:10, pages 1037-1047.
Read now
Read now
Ron Milo & Olaf Stüve. (2016) Spotlight on daclizumab: its potential in the treatment of multiple sclerosis. Degenerative Neurological and Neuromuscular Disease 6, pages 95-109.
Read now
Read now
Articles from other publishers (15)
Francesca Condino, Maria Caterina Crocco, Domenico Pirritano, Alfredo Petrone, Francesco Del Giudice & Rita Guzzi. (2023) A Linear Predictor Based on FTIR Spectral Biomarkers Improves Disease Diagnosis Classification: An Application to Multiple Sclerosis. Journal of Personalized Medicine 13:11, pages 1596.
Crossref
Crossref
Leslie Menendez, Michael Osherov, Zeev Nitsan, Marwan Alkrenawi, Anna Gelfand, Nurit Hovel, Shmuel Appel & Ron Milo. (2023) The consequences of switching from Gilenya® to generics for fingolimod. Multiple Sclerosis and Related Disorders 74, pages 104692.
Crossref
Crossref
David P. Jarmolowicz, Tadd D. Schneider, Justin C. Strickland, Amanda S. Bruce, Derek D. Reed & Jared M. Bruce. (2023) Reinforcer pathology, probabilistic choice, and medication adherence in patients with multiple sclerosis. Journal of the Experimental Analysis of Behavior 119:2, pages 275-285.
Crossref
Crossref
Maria Caterina Crocco, María Fernanda Heredia Moyano, Ferdinanda Annesi, Rosalinda Bruno, Domenico Pirritano, Francesco Del Giudice, Alfredo Petrone, Francesca Condino & Rita Guzzi. (2023) ATR-FTIR spectroscopy of plasma supported by multivariate analysis discriminates multiple sclerosis disease. Scientific Reports 13:1.
Crossref
Crossref
Weipeng Wei, Denglei Ma, Lin Li & Lan Zhang. (2021) Progress in the Application of Drugs for the Treatment of Multiple Sclerosis. Frontiers in Pharmacology 12.
Crossref
Crossref
Ferdinanda Annesi, Sonia Hermoso-Durán, Bruno Rizzuti, Rosalinda Bruno, Domenico Pirritano, Alfredo Petrone, Francesco Del Giudice, Jorge Ojeda, Sonia Vega, Oscar Sanchez-Gracia, Adrian Velazquez-Campoy, Olga Abian & Rita Guzzi. (2021) Thermal Liquid Biopsy (TLB) of Blood Plasma as a Potential Tool to Help in the Early Diagnosis of Multiple Sclerosis. Journal of Personalized Medicine 11:4, pages 295.
Crossref
Crossref
David P. Jarmolowicz, Derek D. Reed, Amanda S. Bruce & Jared M. Bruce. (2019) On the behavioral economics of medication choice: A research story. Behavioural Processes 165, pages 66-77.
Crossref
Crossref
Alzahrani Abdullah, Mohammed Maged, Ibrahim Hairul-Islam M.Alwassil Osama I.Habash Maha, Alfuwaires Manal & Hanieh Hamza. (2019) Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis. PLOS ONE 14:4, pages e0215981.
Crossref
Crossref
Jared M. Bruce, Amanda S. Bruce, Sharon Lynch, Joanie Thelen, Seung-Lark Lim, Julia Smith, Delwyn Catley, Derek D. Reed & David P. Jarmolowicz. (2018) Probability discounting of treatment decisions in multiple sclerosis: associations with disease knowledge, neuropsychiatric status, and adherence. Psychopharmacology 235:11, pages 3303-3313.
Crossref
Crossref
Cheng Fan, Rui Long, Ya You, Jue Wang, Xiaofang Yang, Shiyuan Huang, Yuling Sheng, Xu Peng, Hui Liu, Zhaohui Wang & Kun Liu. (2018) A novel PADRE-Kv1.3 vaccine effectively induces therapeutic antibodies and ameliorates experimental autoimmune encephalomyelitis in rats. Clinical Immunology 193, pages 98-109.
Crossref
Crossref
Kaja Kasarełło, Agnieszka Cudnoch-Jędrzejewska, Andrzej Członkowski & Dagmara Mirowska-Guzel. (2017) Mechanism of action of three newly registered drugs for multiple sclerosis treatment. Pharmacological Reports 69:4, pages 702-708.
Crossref
Crossref
Angela Vidal-Jordana & Xavier Montalban. (2017) Multiple Sclerosis. Neuroimaging Clinics of North America 27:2, pages 195-204.
Crossref
Crossref
Wayra Citlali Paz-Ballesteros, Eric Alejandro Monterrubio-Flores, José de Jesús Flores-Rivera, Teresa Corona-Vázquez & Carlos Hernández-Girón. (2017) Cigarette Smoking, Alcohol Consumption and Overweight in Multiple Sclerosis: Disability Progression. Archives of Medical Research 48:1, pages 113-120.
Crossref
Crossref
Jacques De Keyser. 2017. Noradrenergic Signaling and Astroglia. Noradrenergic Signaling and Astroglia
289
299
.
Yara Dadalti Fragoso, Luana Caramillo Going, Amanda M. Lourido, Leticia V. Berlim, Marcia B.A. Egas & Mariani R. Souza. (2016) Aggressive Traits inPeople with Multiple Sclerosis—A Case–Control Study. Archives of Clinical Neuropsychology.
Crossref
Crossref